Treatment of Breast Cancer in the 1990s
What Does the Future Hold?
- 9 Downloads
KeywordsBreast Cancer Metastatic Breast Cancer Axillary Lymph Node Advanced Breast Cancer Celiprolol
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Bonadonna G. Conceptual and practical advances in the management of breast cancer. Journal of Clinical Oncology 7: 1380–1397, 1987Google Scholar
- Carmo-Pereira J, Costa FO, Henrigues E, et al. Advanced breast carcinoma: a comaprison of two dose levels of adriamycin. Abstract. Proceedings of the American Society of Clinical Oncology 5: 56, 1986Google Scholar
- Fisher B, Slack NH, Cooperating Investigators. Number of lymph nodes examined and the prognosis of breast cancer. Surgery Gynecology and Obstetrics 131: 79–88, 1970Google Scholar
- Hortobagyi GN, Frye D, Buzdar AU, et al. Complete remissions in metastatic breast cancer. Abstract. Proceedings of the American Society of Clinical Oncology 7: 37, 1988Google Scholar
- Peters WP, Davis R, Shpall EJ, Jones RB, et al. Adjuvant chemotherapy involving high-dose combination cyclophosphamide, cisplatin, and carmustine (CPA/cDDP/BCNU) and autologous bone marrow support (ABMS) for stage II/III breast cancer involving ten or more lymph nodes (CALGB 8782): a preliminary report. Abstract. Proceedings of the American Society of Clinical Oncology 9: 22, 1990Google Scholar
- Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma. New England Journal of Medicine 316: 1493–1498, 1987PubMedCrossRefGoogle Scholar
© Adis International Limited 1992